Back to results
US 10,238,688 B2Granted
Combination therapies for bladder cancer
AssigneeGenedia Biotech Co., Ltd.
InventorJingde Zhu
Life of this patent
Estimating the term…
Abstract
The disclosure provides drug combinations and methods for treating human bladder cancer. The drug combination may include mitomycin, or an analog thereof, cisplatin or an alternative platinum drug, and epirubicin or an alternative anthracycline drug and does not include gemcitabine.
Claims13
A method for treating a human patient suffering from bladder cancer, comprising administering to the patient an effective amount of mitomycin, an effective amount of cisplatin and an effective amount of epirubicin, wherein the weight ratio of mitomycin to cisplatin to epirubicin is about 200 to 1500 to 250.
Dependencies are inferred from the claim text.